Charles River Laboratories (CRL) Tops Q3 EPS by 9c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. ANET
6. DUOL
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to Charles River Laboratories (CRL) Tops Q3 EPS by 9c, Offers Guidance

Charles River Laboratories Announces Third-Quarter 2022 Results

November 2, 2022 7:00 AM EDT

Third-Quarter Revenue of $989.2 Million

Third-Quarter GAAP Earnings per Share of $1.88 and Non-GAAP Earnings per Share of $2.63

Narrows 2022 Revenue Growth and Earnings Per Share Guidance

Announces Planned Divestiture of Avian Vaccine Business

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2022. For the quarter, revenue was $989.2 million, an increase of 10.4% from $895.9 million in the third quarter of 2021.

Acquisitions contributed 1.7% to consolidated third-quarter revenue growth. The... More